Slide 1: Progress report – Pulsecor acquisition
For personal use only The Cardiovascular Device Company Progress report – Pulsecor acquisition Rob Phillips Mphil(med), FASE, DMU(cardiol) Chief Executive Officer June 2013 ASX: UCM The measure of life www.uscom.com.au
Slide 2: “The Holy Grail”
“The Holy Grail” For personal use only “Bringing together noninvasive and accurate central blood flow and central blood pressure measurement has been the holy grail of cardiovascular medicine. Uscom now has the technology to do that.” Rob Phillips Uscom CEO/Chairman 2 The measure of life www.uscom.c
Slide 3: Background
Background Uscom (UCM) – Publicly listed medical device company with practice For personal use only leading noninvasive cardiovascular devices and global brand recognition Mission – Operational stabililty, sound capitalisation, global distribution, strategic partnerships, profitability, market leade
Slide 4: USCOM cardiac output monitor
USCOM cardiac output monitor For personal use only Non invasive, accurate, compact, broad based technology platform Accurate cardiac output Integrates with other Stroke volume hospital equipment Heart rate Intuitive touch screen Systemic Real time data vascular resistance Left and right heart measur
Slide 5: USCOM - Gold standard evidence
USCOM - Gold standard evidence For personal use only 250+ Peer reviewed publications and presentations Emergency, Pediatrics, Cardiac transplantation, Electrophysiology, Heart Failure, Emergency transport, Anesthesia, Liver transplantation, ICU, Septic shock, Pre- eclampsia, Pulmonary hypertension,
Slide 6: Platform technology - Strategic partnerships
Platform technology - Strategic partnerships Pharmaceu8cals For personal use only Ultrasound CO module Crit Care CO Monitoring module Home care Ventilation CO module Hypertension, HF and sleep monitoring Pacemaker op8misa8on unit -‐ ElectroCOM Mobile Monitoring module 6 The measure of life www.usco
Slide 7: BP+ Central Blood Pressure Monitor
BP+ Central Blood Pressure Monitor For personal use only Stand alone, non invasive, accurate, compact system Market ready with FDA, CE and TGA approvals Simple and easy to use Suprastolic Central BP+ Suitable for home or clinical use Reliable and accurate Intuitive touch screen Central and Results i
Slide 8: Uscom BP+ - Patented suprasystolic oscillometry
Uscom BP+ - Patented suprasystolic oscillometry For personal use only + Other BP devices + + Heart Vessels + Blood Pressure Plus… demonstrating what others cant! 8
Slide 9: Central Blood Pressure?
Central Blood Pressure? For personal use only Central BP is better than brachial BP “central pulse pressure is more strongly related to vascular hypertrophy, extent of atherosclerosis, and cardiovascular events than is brachial blood pressure” Artery Research 2009;3: 125-7 9 Hypertension 2007;50:197
Slide 10: BP+ Market
BP+ Market For personal use only BP+ Simple and improved solution for hypertension • Hypertension • Effects 25% of all adults • $15b market • US spending on hypertension $80b pa • Markets • Hypertension • Hypertension research • Pregnancy hypertension • ICU, anaesthesia, ED, Paediatrics etc. • Home
Slide 11: Pulsecor Acquisition - Background
Pulsecor Acquisition - Background For personal use only Rationale • Scientific, operational and strategic synergy – 1+1=3 • Great product - with 34 patents and 4 trademarks • FDA, CE and TGA approved products with imminent US re-imbursement • BP market is growing ($15 billion+) • Two products with d
Slide 12: Foundations for growth - product pipeline
Foundations for growth - product pipeline For personal use only Two platform technologies with multiple applications Uscom • USCOM 1A – Advanced haemodynamics • OXYCOM – Real time Oxygen Delivery (DO2) • USCOMt – Haemodynamics transducer • CareCOM – Physiology mapping and treatment guide • EduCOM –
Slide 13: Foundations for growth - Deep R&D pipeline
Foundations for growth - Deep R&D pipeline For personal use only Multiple future products - Small, Telemetric, Continuous, Portable, iPhone Apps, Combined products. 13
Slide 14: Foundations for growth - market opportunities
Foundations for growth - market opportunities For personal use only Huge markets for 2 great products Markets - direct • Hypertension • Congestive Heart failure • Sepsis • Electrophysiology (pacemaker optimisation) • Home care monitoring • Home/GP clinics • Direct sales – BP+ Technology / manufactur
Slide 15: What’s next…
What’s next… For personal use only • Grow global distribution and sales revenues • Consolidate Pulsecor acquisition into Sydney operations • Develop new product pipeline • Continue to build clinical and economic evidence around treatment of major medical conditions • R&D focus to evolve technology t
Slide 16: Investment Achievements - UCM
Investment Achievements - UCM For personal use only 333% 2012 year on year share price – 75% Share price since last raising Oct 2012 – 2013 June – Pulsecor acquisition (unrealised value) Unrecognised value, with opportunity for significant price re-alignment in the growing health sector 16 The measu
Slide 17: Risks
Risks For personal use only • Global medical markets unpredictable • Product development slower and more costly than expected • Distribution slow to achieve revenue goals • Competitive risks • Patent breaches • Inadequate capital 17 The measure of life www.uscom.com.au
Slide 18: Summary
Summary For personal use only • A high-growth, de-risked Australian medical device company • World-leading technologies to transform inefficient medical practices • Strong competitive position in the cardiovascular device market • Leveraging outstanding science into clinical practice and a profitabl
Slide 19: Summary
Summary For personal use only 19 The measure of life www.uscom.com.au
Slide 20: Thank you
USCOM For personal use only Thank you Rob Phillips Chief Executive Officer T: (02) or +61 418681154 E: rob@uscom.com.au 20 The measure of life www.uscom.com.au